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Abstract
Here we briefly report testosterone and cytokine responses to Venezuelan equine encephalitis
virus (VEEV) in macaques which were used as part of a larger study conducted by the Department
of Defense to better characterize pathological responses to aerosolized VEEV in non-human
primates. Serial samples were collected and analyzed for testosterone and cytokines prior to and
during infection in 8 captive male macaques. Infected animals exhibited a febrile response with few
significant changes in cytokine levels. Baseline testosterone levels were positively associated with
viremia following exposure and were significantly higher than levels obtained during infection. Such
findings suggest that disease-induced androgen suppression is a reasonable area for future study.
Decreased androgen levels during physiological perturbations may function, in part, to prevent
immunosuppression by high testosterone levels and to prevent the use of energetic resources for
metabolically-expensive anabolic functions.
Findings
Venezuelan equine encephalitis virus (VEEV) complex,
like the Western and Eastern equine encephalitis virus
complexes, is a collection of alphaviruses (single, positive
strand RNA) of the family Togaviridae that infect humans,
rodents and equines in the Americas, and are transmitted
via various arthropods, including mosquitoes such as
Aedes, Culex, and Psorophora [1]. VEEV is a neurotropic
virus in laboratory rodents that induces illness character-
ized first by replication in the lymphoid tissues and devel-
opment of a high viremia, and second by invasion of the
central nervous system via the olfactory neuroepithelium
resulting in encephalitis [2-4]. The murine immune
response to VEEV is characterized by both Th-1 and Th-2
cytokine gene expression, and both antibody- and cell-
mediated responses may play important roles in protec-
tion against VEEV [5,6]. Among human and non-human
primates, the virus is much less fatal, usually resulting in
fever with viremia and lymphopenia [7]. The specific
immune responses to VEEV in humans or non-human pri-
mates are not well known.
Here we report preliminary results describing the testo-
sterone and cytokine responses to VEEV in macaques
which were used as part of a larger study conducted by the
Department of Defense to better characterize pathological
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responses to aerosolized VEEV in non-human primates.
Ample evidence suggests that testosterone is inversely
associated with measures of immunity in several species,
including primates [8-11]. It was therefore hypothesized
that testosterone would be directly associated with VEEV
viremia and inversely associated with proinflammatory
cytokine levels.
Eleven captive-born, adult (mean age: 9.74 years) male
cynomolgus monkeys (Macaco fasicularis) were main-
tained in individual steel cages in a BSL-3 facility at the
United States Army Medical Research Institute of Infec-
tious Diseases (USAMRIID), Fort Detrick, Maryland. Ani-
mals were maintained on a standard laboratory primate
diet, and water was available ad libitum. All animals
tested negative for antibodies to Western, Eastern, and
Venezuelan Equine Encephalitis viruses before their use in
this experiment.
Blood samples were obtained on pre-exposure days -60, -
45, and -30. On pre-exposure day -30, each animal was
implanted with a Data Sciences International TA11PA-
C40 Temperature and Activity Telemetry Transmitter. On
day 0 (day of exposure), 8 radomly chosen animals were
exposed to a total inhaled dose of 1 × 108 plaque forming
units (PFU) of VEEV, Trinidad Donkey strain. Every 24
hours post-exposure, 2 of the 8 infected animals were ran-
domly chosen to be anesthetized and euthanized by
exsanguination. Euthanasia and single interval sampling,
rather than multiple bleeds throughout infection, were
the requirement of another study by the Department of
Defense using these same animals.
For each blood sample, animals were anesthetized with
0.1 mg/kg ketamine/acepromazine maleate solution and
a 6 ml blood sample was immediately obtained from the
femoral vein using a Vacutainer tube with serum separa-
tor. Samples were centrifuged, the serum frozen at - 80°C,
and aliquots shipped to Yale University and Tulane Uni-
versity. Samples from the two animals which were
exposed to VEEV and sampled/sacrificed 24 hours later
(day 1) were not available for analysis in the current
study, thus the final size was as follows: 3 baseline sam-
ples taken from each of 11 animals (N = 33); 1 sample
taken from each of 2 animals 48 hours after exposure (N
= 2); 1 sample taken from each of 2 animals 72 hours after
exposure (N = 2); 1 sample taken from each of 2 animals
96 hours after exposure (N = 2). Because of ethical con-
cerns and costs associated with the use of non-human pri-
mates, and because this project utilized animals from a
study in progress by the Department of Defense, sample
sizes could not be increased for purposes described here.
Research was conducted in compliance with the Animal
Welfare Act and other Federal statutes and regulations
relating to animals and experiments involving animals
and adheres to principles stated in the Guide for the Care
and Use of Laboratory Animals, National Research Coun-
cil, 1996. The facility where this research was conducted is
fully accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care International.
At Yale University, samples were assayed for total testo-
sterone and cortisol levels using coated-tube radioimmu-
noassay kits (DSL-4000 and DSL-2100) from Diagnostic
Systems Laboratories (DSL), Webster, Texas. The sensitiv-
ities of the assays were 0.08 ng/ml for testosterone and 0.3
ng/dl for cortisol. The correlation coefficients for each of
the curves were better than 0.99. High and low level DSL
controls were included in each standard curve; results for
the controls in each assay were within established confi-
dence limits. Intra-assay coefficients of variation were
assessed using the mean coefficients of variation of con-
trol duplicates. Intra-assay coefficients of variation were
5.8% for testosterone and 9.1% for cortisol. All samples
were run in a single assay, therefore there were no inter-
assay coefficients of variation to assess. For each individ-
ual animal, hormone values from the pre-exposure sam-
ples on days -60, -45, and -30 were averaged to yield a
baseline (pre-exposure) level.
At Tulane University, samples were assayed for the follow-
ing cytokines using enzyme-linked immunosorbent assay:
IL-1β, IL-4, IL-10, IL-12, TNFα, and IFNγ (Biosource Inter-
national Inc., Camarillo, CA, USA). Of each of these kits,
all but IL-1β (human IL-lβ kit) was designed specifically
for use in macaques. The human IL-1β kit demonstrates
100% cross-reactivity with non-human primate samples
(S. Durham, BioSource International, Technical Services,
personal communication). The sensitivities of the assays
were: IFNγ : <4 pg/ml; TNFα : <2 pg/ml; IL-1β : 1 pg/ml;
IL-4: <3 pg/ml; IL-10: <10 pg/ml; IL-12: <4 pg/ml. The
correlation coefficients for each of the curves were better
than 0.96. Intra-assay coefficients of variation were
assessed using the mean coefficients of variation of con-
trol duplicates. Intra-assay coefficients of variation were:
IFNγ: 5.1%; TNFα : 3.7%; IL-1β : 4.7%; IL-4: 5.4%; IL-10:
5.1%; IL-12: 4.3%. All samples were run on a single assay,
and therefore there were no inter-assay coefficients of var-
iation to assess.
At USAMRIID, viremia was determined by titration of
samples on tissue culture (VERO 76) cells and enumera-
tion of plaques (plaque forming units: PFUs). Viremia
was measured only on the day of sacrifice, and therefore
this measure does not reflect peak viremia titers.
Data were analyzed using SAS/STAT software (SAS Insti-
tute Inc., Gary, NC). The Wilcoxon Signed Rank test was
used to test whether the median change in temperature,Virology Journal 2006, 3:19 http://www.virologyj.com/content/3/1/19
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testosterone, cortisol, or cytokine values from the pre-
exposure samples to the sacrifice (exposure) samples were
significantly different from zero (no change). Spearman
correlations were used to determine associations between
the various variables. Cortisol levels were determined and
controlled for in (as a covariate) all analyses involving tes-
tosterone because cortisol exhibits mainly inhibitory
effects on immune function and because cortisol is often
associated with suppression of the hypothalamic-pitui-
tary-testicular axis [12,13]. As the immunosuppressive
actions of glucocorticoids are better characterized than
that of androgens, the focus of this study was testosterone
rather than cortisol-related effects. Additionally, level of
significance (alpha) was set at 0.10 so as to err on the side
of conservatism (to avoid false negatives) given the small
sample size. Power analyses for the Wilcoxon Signed Rank
tests were performed with the SAS/STAT Analyst Sample
Size application for paired t-tests (SAS Institute Inc., Gary,
NC) to assess the likelihood of false negatives. Power (%)
is reported below for those tests that revealed non-signifi-
cant results.
Temperature, virus titer, testosterone and cytokine levels
were compared between samples taken prior to exposure
and on the day of sacrifice (48, 72, or 96 hours post-expo-
sure, depending on animal). Mean temperature at time of
sacrifice (37.25°C) was significantly higher (T = 10.5, p =
0.03) than mean temperature prior to VEEV exposure
(35.89°C). Mean testosterone level at time of sacrifice
(13.37 ng/ml) was significantly lower (T = -8.5, p = 0.094)
than testosterone level prior to VEEV exposure (19.51 ng/
ml). Table 1 presents viremia and pre-and post-infection
testosterone levels for each of the six animals infected
with VEEV.
Statistical analyses could only be performed on IL-12 and
IL-10 levels because TNFα and IL-4 levels were not above
a detectable level for any sample of any animal, and only
one animal had IL-1β and IFNγ values greater than zero.
Mean IL-12 prior to exposure was 537.36 pg/ml, which
was significantly higher (T = -10.5, p = 0.03) than mean
IL-12 at time of sacrifice (280.66 pg/ml). Mean IL-10 prior
to exposure was 286.35 pg/ml, which was not signifi-
cantly different (T = -3.0, p = 0.25, power = 20%) from
mean IL-10 at time of sacrifice (236.07 pg/ml).
Viremia was available from only 6 of the 8 animals which
were exposed to VEEV. Virus titers were highest in animals
sacrificed at 48 hours than in those other animals of
known viremia. Virus titers for the six animals were as fol-
lows: 7800 PFU per ml of blood for the two animals sac-
rificed 48 hours post-exposure; 370 PFU per ml for the
two animals sacrificed 72 hours post-exposure; and 50
and 25 PFU per ml for the two animals sacrificed 96 hours
post-exposure.
Pre-exposure testosterone and cortisol levels were both
positively associated with viremia levels after exposure (r
= 0.98, p = 0.02 and r = 0.96, p = 0.04, respectively; con-
trolling for the hours between exposure and sacrifice; tes-
tosterone correlation controlling for cortisol levels, and
vice versa).
The results of this preliminary study suggest that: 1)
macaques infected with VEEV exhibit a febrile response
with possibly few significant changes in cytokine levels; 2)
higher levels of testosterone (when controlling for corti-
sol) prior to virus exposure may be directly associated
with higher viremia after exposure; and 3) testosterone
levels are lower during infection with VEEV than prior to
infection.
First, macaques infected with VEEV exhibited a significant
febrile response with few significant changes in cytokine
levels. That is, temperature levels were elevated, IL-12 lev-
els were lower, and IL-10 levels were relatively unchanged
during infection. In both humans and non-human pri-
mates, VEEV infection has been characterized by fever
with viremia and lymphopenia [7] Unfortunately, no
definitive conclusion can be drawn regarding the cytokine
response to VEEV in the present study utilizing macaques
because of the small sample size, lack of statistical power,
and inability to assess the acute phase of infection (the
sample was lacking information from animals at the 24
hour post-exposure timepoint). Furthermore, exposure to
VEEV was not followed-up for longer than 96 hours, and
Table 1: Viremia and pre- and post-infection testosterone levels for each of six animals infected with VEEV
Animal ID Viremia (PFU) at
time of sacrifice
Time (hrs) between
exposure and sacrifice
Testosterone (ng/ml) at
time of sacrifice
Pre-exposure testosterone 
(ng/ml)
(mean for each animal)
1 7800 48 15.58 28.14
2 7800 48 20.43 26.29
3 370 72 22.06 16.44
4 370 72 2.81 13.11
5 50 96 12.56 25.07
6 25 96 6.79 8.01Virology Journal 2006, 3:19 http://www.virologyj.com/content/3/1/19
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only a single sample was obtained from each animal
throughout this short infection period.
Second, higher levels of testosterone prior to virus expo-
sure were directly associated with higher viremia after
exposure. That is, when controlling for time between
exposure and sacrifice as well as cortisol levels, pre-expo-
sure testosterone levels were significantly (directly) associ-
ated with viremia in post-exposure samples. In general,
the effects of testosterone on viral infections, incluyding
HIV and Sindbis virus, are equivocal [11,14,15]. It may be
the case that testosterone plays an immunosuppressive
role in response to viral infection in male macaques and
that higher levels of basal testosterone levels may increase
an animal's susceptibility to viral infection. Future studies
are warranted.
Thirdly, testosterone levels were significantly lower during
infection with VEEV than prior to infection. Similarly,
serum testosterone decreases during the onset of various
conditions, including Plasmodium vivax infection in Hon-
duran men [16], surgery and trauma in men [17], and
Trypanosoma brucei brucei infection in rats [18]. Further-
more, testicular atrophy and azoospermia have been
reported from men who died of AIDS [19], and azoosper-
mia has been associated with SIV infection in young male
rhesus macaques [20]. Depressed androgen levels during
physiological perturbations may be an advantageous,
adaptive host response in order to prevent immunosup-
pression by high testosterone levels and to re-direct ener-
getic resources [21-23], specifically away from
metabolically-expensive anabolic functions [11].
Although the results of the present study are very prelimi-
nary, they do suggest that disease-induced androgen sup-
pression is a reasonable area for future study.
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